Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Journal of Epidemiology and Community Health|November 15, 2007
Use of statins and beta-blockers after acute myocardial infarction according to income and educationJeppe N Rasmussen, Gunnar H Gislason, Søren Rasmussen, et al.
The New England Journal of Medicine|August 31, 2017
Liraglutide and Renal Outcomes in Type 2 DiabetesJohannes F E Mann, David D Ørsted, Kirstine Brown-Frandsen, et al.
Cardiovascular Drugs and Therapy|October 24, 2007
Persistent socio-economic differences in revascularization after acute myocardial infarction despite a universal health care system-a Danish studyJeppe N Rasmussen, Søren Rasmussen, Gunnar H Gislason, et al.
British Journal of Clinical Pharmacology|July 27, 2005
Statin use after acute myocardial infarction: a nationwide study in DenmarkJeppe N Rasmussen, Gunnar H Gislason, Steen Z Abildstrom, et al.
Skeletal Radiology|April 23, 2024
Radiographic findings in patients suspected of subacromial impingement syndrome: prevalence and reliabilityLinda Christie Andrea, Susanne Wulff Svendsen, Poul Frost, et al.
European Heart Journal|January 10, 2006
Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarctionGunnar H Gislason, Jeppe N Rasmussen, Steen Z Abildstrøm, et al.
Diabetes, Obesity & Metabolism|March 10, 2019
Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trialsSubodh Verma, Stephen C Bain, Tea Monk Fries, et al.
Circulation|June 21, 2006
Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarctionGunnar H Gislason, Søren Jacobsen, Jeppe N Rasmussen, et al.
Diabetes, Obesity & Metabolism|May 7, 2020
The effect of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trialsLawrence A Leiter, Stephen C Bain, Deepak L Bhatt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 2, 2024
Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6Ellen M Apperloo, David Z I Cherney, Anja Birk Kuhlman, et al.
Pageof 11